Both will develop cancer vaccine candidates in selected haematological and solid tumour indications
Category: Oncology
Despite tremendous advances in breast cancer research and treatment over the past three decades many groups are systematically […]
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest […]
Solid tumour cancers account for 90% of adult human cancers and 50% of childhood malignancies
Both will validate the clinical performance of two new diagnostic tests for regulatory submission
Around three million people in the UK were estimated to be living with cancer in 2022
Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow
The project will assist researchers and companies in training the technology for healthcare settings
The third most common and serious form of cancer affects over 43,000 people every year in the UK